APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tubular Injection Vial

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tubular Injection Vial Market Outlook and Growth Opportunities 2026

5 June 2026217 pages

Choose your research edition.

Industry ResearchTubular Injection Vial Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Tubular Injection Vial Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tubular Injection Vial Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tubular Injection Vial Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Tubular Injection Vial Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Tubular Injection Vial market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tubular Injection Vial is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tubular Injection Vial is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tubular Injection Vial is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tubular Injection Vial market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tubular Injection Vial market include SGD, SCHOTT Pharma, Gerresheimer AG, DWK Life Sciences, Stevanato Group, Corning, Nipro Corporation, Daikyo Seiko and West Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tubular Injection Vial market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tubular Injection Vial and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tubular Injection Vial sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tubular Injection Vial market size, projected growth trends, production technologies, key applications, and end-use industries.

Tubular Injection Vial Segment by Company

SGD

SCHOTT Pharma

Gerresheimer AG

DWK Life Sciences

Stevanato Group

Corning

Nipro Corporation

Daikyo Seiko

West Pharmaceutical

Radpharm Scientific

Pacific Vial Manufacturing

Ningbo Zhengli Pharmaceutical Packaging

Linuo Pharmaceutical Packaging

Chongqing Zhengchuan Pharmaceutical Packaging

Shandong Pharmaceutical Glass

CANGZHOU FOUR STARS GLASS

Anhui Huaxin Pharmaceutical Glass Products

Jiyuan Zhengyu Industrial

Taian Youlyy Industrial

Nantong Xinde Medical Packing Material

Chengdu Jingu Medicinal Packing

Tubular Injection Vial Segment by Type

Low Borosilicate Tubular Injection Vial

Medium Borosilicate Tubular Injection Vial

High Borosilicate Tubular Injection Vial

Soda-lime Tubular Injection Vial

Tubular Injection Vial Segment by Application

Biologicals

Lyophilized Powder Injection

Vaccines

Other

Tubular Injection Vial Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tubular Injection Vial status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tubular Injection Vial market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tubular Injection Vial significant trends, drivers, influence factors in global and regions.

6. To analyze Tubular Injection Vial competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tubular Injection Vial market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tubular Injection Vial and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tubular Injection Vial.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tubular Injection Vial market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tubular Injection Vial industry.

Chapter 3: Detailed analysis of Tubular Injection Vial manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tubular Injection Vial in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tubular Injection Vial in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tubular Injection Vial Industry Trends Table 2. Tubular Injection Vial Industry Drivers Table 3. Tubular Injection Vial Industry Opportunities and Challenges Table 4. Tubular Injection Vial Industry Restraints Table 5. Global Tubular Injection Vial Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tubular Injection Vial Revenue Share by Company (2021-2026) Table 7. Global Tubular Injection Vial Sales Volume by Company (M units) & (2021-2026) Table 8. Global Tubular Injection Vial Sales Volume Share by Company (2021-2026) Table 9. Global Tubular Injection Vial Average Price (USD/unit) of Company (2021-2026) Table 10. Global Tubular Injection Vial Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tubular Injection Vial Key Company Manufacturing Base & Headquarters Table 12. Global Tubular Injection Vial Company, Product Type & Application Table 13. Global Tubular Injection Vial Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tubular Injection Vial by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Low Borosilicate Tubular Injection Vial Table 18. Significant Companies of Medium Borosilicate Tubular Injection Vial Table 19. Significant Companies of High Borosilicate Tubular Injection Vial Table 20. Significant Companies of Soda-lime Tubular Injection Vial Table 21. Global Tubular Injection Vial Sales Volume by Type 2021 VS 2025 VS 2032 (M units) Table 22. Global Tubular Injection Vial Sales Volume by Type (2021-2026) & (M units) Table 23. Global Tubular Injection Vial Sales Volume by Type (2027-2032) & (M units) Table 24. Global Tubular Injection Vial Sales Volume Share by Type (2021-2026) Table 25. Global Tubular Injection Vial Sales Volume Share by Type (2027-2032) Table 26. Global Tubular Injection Vial Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Tubular Injection Vial Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Tubular Injection Vial Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Tubular Injection Vial Sales Value Share by Type (2021-2026) Table 30. Global Tubular Injection Vial Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Biologicals Table 32. Significant Companies of Lyophilized Powder Injection Table 33. Significant Companies of Vaccines Table 34. Significant Companies of Other Table 35. Global Tubular Injection Vial Sales Volume by Application 2021 VS 2025 VS 2032 (M units) Table 36. Global Tubular Injection Vial Sales Volume by Application (2021-2026) & (M units) Table 37. Global Tubular Injection Vial Sales Volume by Application (2027-2032) & (M units) Table 38. Global Tubular Injection Vial Sales Volume Share by Application (2021-2026) Table 39. Global Tubular Injection Vial Sales Volume Share by Application (2027-2032) Table 40. Global Tubular Injection Vial Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Tubular Injection Vial Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Tubular Injection Vial Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Tubular Injection Vial Sales Value Share by Application (2021-2026) Table 44. Global Tubular Injection Vial Sales Value Share by Application (2027-2032) Table 45. Global Tubular Injection Vial Sales by Region: 2021 VS 2025 VS 2032 (M units) Table 46. Global Tubular Injection Vial Sales by Region (2021-2026) & (M units) Table 47. Global Tubular Injection Vial Sales Market Share by Region (2021-2026) Table 48. Global Tubular Injection Vial Sales by Region (2027-2032) & (M units) Table 49. Global Tubular Injection Vial Sales Market Share by Region (2027-2032) Table 50. Global Tubular Injection Vial Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Tubular Injection Vial Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Tubular Injection Vial Sales Value Share by Region (2021-2026) Table 53. Global Tubular Injection Vial Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Tubular Injection Vial Sales Value Share by Region (2027-2032) Table 55. Global Tubular Injection Vial Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Tubular Injection Vial Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Tubular Injection Vial Sales by Country: 2021 VS 2025 VS 2032 (M units) Table 58. Global Tubular Injection Vial Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 60. Global Tubular Injection Vial Sales Market Share by Country (2021-2026) Table 61. Global Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 62. Global Tubular Injection Vial Sales Market Share by Country (2027-2032) Table 63. Global Tubular Injection Vial Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Tubular Injection Vial Sales Value Market Share by Country (2021-2026) Table 65. Global Tubular Injection Vial Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Tubular Injection Vial Sales Value Market Share by Country (2027-2032) Table 67. SGD Company Information Table 68. SGD Business Overview Table 69. SGD Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. SGD Tubular Injection Vial Product Portfolio Table 71. SGD Recent Development Table 72. SCHOTT Pharma Company Information Table 73. SCHOTT Pharma Business Overview Table 74. SCHOTT Pharma Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. SCHOTT Pharma Tubular Injection Vial Product Portfolio Table 76. SCHOTT Pharma Recent Development Table 77. Gerresheimer AG Company Information Table 78. Gerresheimer AG Business Overview Table 79. Gerresheimer AG Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Gerresheimer AG Tubular Injection Vial Product Portfolio Table 81. Gerresheimer AG Recent Development Table 82. DWK Life Sciences Company Information Table 83. DWK Life Sciences Business Overview Table 84. DWK Life Sciences Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. DWK Life Sciences Tubular Injection Vial Product Portfolio Table 86. DWK Life Sciences Recent Development Table 87. Stevanato Group Company Information Table 88. Stevanato Group Business Overview Table 89. Stevanato Group Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Stevanato Group Tubular Injection Vial Product Portfolio Table 91. Stevanato Group Recent Development Table 92. Corning Company Information Table 93. Corning Business Overview Table 94. Corning Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Corning Tubular Injection Vial Product Portfolio Table 96. Corning Recent Development Table 97. Nipro Corporation Company Information Table 98. Nipro Corporation Business Overview Table 99. Nipro Corporation Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Nipro Corporation Tubular Injection Vial Product Portfolio Table 101. Nipro Corporation Recent Development Table 102. Daikyo Seiko Company Information Table 103. Daikyo Seiko Business Overview Table 104. Daikyo Seiko Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Daikyo Seiko Tubular Injection Vial Product Portfolio Table 106. Daikyo Seiko Recent Development Table 107. West Pharmaceutical Company Information Table 108. West Pharmaceutical Business Overview Table 109. West Pharmaceutical Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. West Pharmaceutical Tubular Injection Vial Product Portfolio Table 111. West Pharmaceutical Recent Development Table 112. Radpharm Scientific Company Information Table 113. Radpharm Scientific Business Overview Table 114. Radpharm Scientific Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Radpharm Scientific Tubular Injection Vial Product Portfolio Table 116. Radpharm Scientific Recent Development Table 117. Pacific Vial Manufacturing Company Information Table 118. Pacific Vial Manufacturing Business Overview Table 119. Pacific Vial Manufacturing Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Pacific Vial Manufacturing Tubular Injection Vial Product Portfolio Table 121. Pacific Vial Manufacturing Recent Development Table 122. Ningbo Zhengli Pharmaceutical Packaging Company Information Table 123. Ningbo Zhengli Pharmaceutical Packaging Business Overview Table 124. Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 126. Ningbo Zhengli Pharmaceutical Packaging Recent Development Table 127. Linuo Pharmaceutical Packaging Company Information Table 128. Linuo Pharmaceutical Packaging Business Overview Table 129. Linuo Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Linuo Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 131. Linuo Pharmaceutical Packaging Recent Development Table 132. Chongqing Zhengchuan Pharmaceutical Packaging Company Information Table 133. Chongqing Zhengchuan Pharmaceutical Packaging Business Overview Table 134. Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 136. Chongqing Zhengchuan Pharmaceutical Packaging Recent Development Table 137. Shandong Pharmaceutical Glass Company Information Table 138. Shandong Pharmaceutical Glass Business Overview Table 139. Shandong Pharmaceutical Glass Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Shandong Pharmaceutical Glass Tubular Injection Vial Product Portfolio Table 141. Shandong Pharmaceutical Glass Recent Development Table 142. CANGZHOU FOUR STARS GLASS Company Information Table 143. CANGZHOU FOUR STARS GLASS Business Overview Table 144. CANGZHOU FOUR STARS GLASS Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. CANGZHOU FOUR STARS GLASS Tubular Injection Vial Product Portfolio Table 146. CANGZHOU FOUR STARS GLASS Recent Development Table 147. Anhui Huaxin Pharmaceutical Glass Products Company Information Table 148. Anhui Huaxin Pharmaceutical Glass Products Business Overview Table 149. Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Product Portfolio Table 151. Anhui Huaxin Pharmaceutical Glass Products Recent Development Table 152. Jiyuan Zhengyu Industrial Company Information Table 153. Jiyuan Zhengyu Industrial Business Overview Table 154. Jiyuan Zhengyu Industrial Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Jiyuan Zhengyu Industrial Tubular Injection Vial Product Portfolio Table 156. Jiyuan Zhengyu Industrial Recent Development Table 157. Taian Youlyy Industrial Company Information Table 158. Taian Youlyy Industrial Business Overview Table 159. Taian Youlyy Industrial Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Taian Youlyy Industrial Tubular Injection Vial Product Portfolio Table 161. Taian Youlyy Industrial Recent Development Table 162. Nantong Xinde Medical Packing Material Company Information Table 163. Nantong Xinde Medical Packing Material Business Overview Table 164. Nantong Xinde Medical Packing Material Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Nantong Xinde Medical Packing Material Tubular Injection Vial Product Portfolio Table 166. Nantong Xinde Medical Packing Material Recent Development Table 167. Chengdu Jingu Medicinal Packing Company Information Table 168. Chengdu Jingu Medicinal Packing Business Overview Table 169. Chengdu Jingu Medicinal Packing Tubular Injection Vial Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Chengdu Jingu Medicinal Packing Tubular Injection Vial Product Portfolio Table 171. Chengdu Jingu Medicinal Packing Recent Development Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Tubular Injection Vial Distributors List Table 175. Tubular Injection Vial Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Tubular Injection Vial Product Image Figure 2. Global Tubular Injection Vial Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tubular Injection Vial Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tubular Injection Vial Sales (2021-2032) & (M units) Figure 5. Global Tubular Injection Vial Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Tubular Injection Vial Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Low Borosilicate Tubular Injection Vial Image Figure 10. Medium Borosilicate Tubular Injection Vial Image Figure 11. High Borosilicate Tubular Injection Vial Image Figure 12. Soda-lime Tubular Injection Vial Image Figure 13. Global Tubular Injection Vial Sales Volume by Type (2021 VS 2025 VS 2032) & (M units) Figure 14. Global Tubular Injection Vial Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Tubular Injection Vial Sales Volume Share by Type (2021-2032) Figure 16. Global Tubular Injection Vial Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Tubular Injection Vial Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Tubular Injection Vial Sales Value Share by Type (2021-2032) Figure 19. Biologicals Image Figure 20. Lyophilized Powder Injection Image Figure 21. Vaccines Image Figure 22. Other Image Figure 23. Global Tubular Injection Vial Sales Volume by Application (2021 VS 2025 VS 2032) & (M units) Figure 24. Global Tubular Injection Vial Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Tubular Injection Vial Sales Volume Share by Application (2021-2032) Figure 26. Global Tubular Injection Vial Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Tubular Injection Vial Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Tubular Injection Vial Sales Value Share by Application (2021-2032) Figure 29. Global Tubular Injection Vial Sales by Region: 2021 VS 2025 VS 2032 (M units) Figure 30. Global Tubular Injection Vial Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Tubular Injection Vial Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Tubular Injection Vial Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Tubular Injection Vial Sales Value (2021-2032) & (US$ Million) Figure 34. North America Tubular Injection Vial Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Tubular Injection Vial Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Tubular Injection Vial Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Tubular Injection Vial Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Tubular Injection Vial Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Tubular Injection Vial Sales Value (2021-2032) & (US$ Million) Figure 40. South America Tubular Injection Vial Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Tubular Injection Vial Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Tubular Injection Vial Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Tubular Injection Vial Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Tubular Injection Vial Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Tubular Injection Vial Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Low Borosilicate Tubular Injection Vial
  • Medium Borosilicate Tubular Injection Vial
  • High Borosilicate Tubular Injection Vial
  • Soda-lime Tubular Injection Vial
Applications
  • Biologicals
  • Lyophilized Powder Injection
  • Vaccines
  • Other
Companies covered
  • SGD
  • SCHOTT Pharma
  • Gerresheimer AG
  • DWK Life Sciences
  • Stevanato Group
  • Corning
  • Nipro Corporation
  • Daikyo Seiko
  • West Pharmaceutical
  • Radpharm Scientific
  • Pacific Vial Manufacturing
  • Ningbo Zhengli Pharmaceutical Packaging
  • Linuo Pharmaceutical Packaging
  • Chongqing Zhengchuan Pharmaceutical Packaging
  • Shandong Pharmaceutical Glass
  • CANGZHOU FOUR STARS GLASS
  • Anhui Huaxin Pharmaceutical Glass Products
  • Jiyuan Zhengyu Industrial
  • Taian Youlyy Industrial
  • Nantong Xinde Medical Packing Material
  • Chengdu Jingu Medicinal Packing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tubular Injection Vial Sales Value (2021-2032)
  4. 1.2.2 Global Tubular Injection Vial Sales Volume (2021-2032)
  5. 1.2.3 Global Tubular Injection Vial Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tubular Injection Vial Market Dynamics
  1. 2.1 Tubular Injection Vial Industry Trends
  2. 2.2 Tubular Injection Vial Industry Drivers
  3. 2.3 Tubular Injection Vial Industry Opportunities and Challenges
  4. 2.4 Tubular Injection Vial Industry Restraints
3 Tubular Injection Vial Market by Company
  1. 3.1 Global Tubular Injection Vial Company Revenue Ranking in 2025
  2. 3.2 Global Tubular Injection Vial Revenue by Company (2021-2026)
  3. 3.3 Global Tubular Injection Vial Sales Volume by Company (2021-2026)
  4. 3.4 Global Tubular Injection Vial Average Price by Company (2021-2026)
  5. 3.5 Global Tubular Injection Vial Company Ranking (2024-2026)
  6. 3.6 Global Tubular Injection Vial Company Manufacturing Base and Headquarters
  7. 3.7 Global Tubular Injection Vial Company Product Type and Application
  8. 3.8 Global Tubular Injection Vial Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tubular Injection Vial Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tubular Injection Vial Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tubular Injection Vial Market by Type
  1. 4.1 Tubular Injection Vial Type Introduction
  2. 4.1.1 Low Borosilicate Tubular Injection Vial
  3. 4.1.2 Medium Borosilicate Tubular Injection Vial
  4. 4.1.3 High Borosilicate Tubular Injection Vial
  5. 4.1.4 Soda-lime Tubular Injection Vial
  6. 4.2 Global Tubular Injection Vial Sales Volume by Type
  7. 4.2.1 Global Tubular Injection Vial Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Tubular Injection Vial Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Tubular Injection Vial Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Tubular Injection Vial Sales Value by Type
  11. 4.3.1 Global Tubular Injection Vial Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Tubular Injection Vial Sales Value by Type (2021-2032)
  13. 4.3.3 Global Tubular Injection Vial Sales Value Share by Type (2021-2032)
5 Tubular Injection Vial Market by Application
  1. 5.1 Tubular Injection Vial Application Introduction
  2. 5.1.1 Biologicals
  3. 5.1.2 Lyophilized Powder Injection
  4. 5.1.3 Vaccines
  5. 5.1.4 Other
  6. 5.2 Global Tubular Injection Vial Sales Volume by Application
  7. 5.2.1 Global Tubular Injection Vial Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tubular Injection Vial Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Tubular Injection Vial Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Tubular Injection Vial Sales Value by Application
  11. 5.3.1 Global Tubular Injection Vial Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Tubular Injection Vial Sales Value by Application (2021-2032)
  13. 5.3.3 Global Tubular Injection Vial Sales Value Share by Application (2021-2032)
6 Tubular Injection Vial Regional Sales and Value Analysis
  1. 6.1 Global Tubular Injection Vial Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tubular Injection Vial Sales by Region (2021-2032)
  3. 6.2.1 Global Tubular Injection Vial Sales by Region: 2021-2026
  4. 6.2.2 Global Tubular Injection Vial Sales by Region (2027-2032)
  5. 6.3 Global Tubular Injection Vial Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tubular Injection Vial Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tubular Injection Vial Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tubular Injection Vial Sales Value by Region (2027-2032)
  9. 6.5 Global Tubular Injection Vial Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tubular Injection Vial Sales Value (2021-2032)
  12. 6.6.2 North America Tubular Injection Vial Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tubular Injection Vial Sales Value (2021-2032)
  15. 6.7.2 Europe Tubular Injection Vial Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tubular Injection Vial Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tubular Injection Vial Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tubular Injection Vial Sales Value (2021-2032)
  21. 6.9.2 South America Tubular Injection Vial Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tubular Injection Vial Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tubular Injection Vial Sales Value Share by Country, 2025 VS 2032
7 Tubular Injection Vial Country-level Sales and Value Analysis
  1. 7.1 Global Tubular Injection Vial Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tubular Injection Vial Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tubular Injection Vial Sales by Country (2021-2032)
  4. 7.3.1 Global Tubular Injection Vial Sales by Country (2021-2026)
  5. 7.3.2 Global Tubular Injection Vial Sales by Country (2027-2032)
  6. 7.4 Global Tubular Injection Vial Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tubular Injection Vial Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tubular Injection Vial Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tubular Injection Vial Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tubular Injection Vial Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tubular Injection Vial Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SGD
  2. 8.1.1 SGD Company Information
  3. 8.1.2 SGD Business Overview
  4. 8.1.3 SGD Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 SGD Tubular Injection Vial Product Portfolio
  6. 8.1.5 SGD Recent Developments
  7. 8.2 SCHOTT Pharma
  8. 8.2.1 SCHOTT Pharma Company Information
  9. 8.2.2 SCHOTT Pharma Business Overview
  10. 8.2.3 SCHOTT Pharma Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 SCHOTT Pharma Tubular Injection Vial Product Portfolio
  12. 8.2.5 SCHOTT Pharma Recent Developments
  13. 8.3 Gerresheimer AG
  14. 8.3.1 Gerresheimer AG Company Information
  15. 8.3.2 Gerresheimer AG Business Overview
  16. 8.3.3 Gerresheimer AG Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Gerresheimer AG Tubular Injection Vial Product Portfolio
  18. 8.3.5 Gerresheimer AG Recent Developments
  19. 8.4 DWK Life Sciences
  20. 8.4.1 DWK Life Sciences Company Information
  21. 8.4.2 DWK Life Sciences Business Overview
  22. 8.4.3 DWK Life Sciences Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 DWK Life Sciences Tubular Injection Vial Product Portfolio
  24. 8.4.5 DWK Life Sciences Recent Developments
  25. 8.5 Stevanato Group
  26. 8.5.1 Stevanato Group Company Information
  27. 8.5.2 Stevanato Group Business Overview
  28. 8.5.3 Stevanato Group Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Stevanato Group Tubular Injection Vial Product Portfolio
  30. 8.5.5 Stevanato Group Recent Developments
  31. 8.6 Corning
  32. 8.6.1 Corning Company Information
  33. 8.6.2 Corning Business Overview
  34. 8.6.3 Corning Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Corning Tubular Injection Vial Product Portfolio
  36. 8.6.5 Corning Recent Developments
  37. 8.7 Nipro Corporation
  38. 8.7.1 Nipro Corporation Company Information
  39. 8.7.2 Nipro Corporation Business Overview
  40. 8.7.3 Nipro Corporation Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nipro Corporation Tubular Injection Vial Product Portfolio
  42. 8.7.5 Nipro Corporation Recent Developments
  43. 8.8 Daikyo Seiko
  44. 8.8.1 Daikyo Seiko Company Information
  45. 8.8.2 Daikyo Seiko Business Overview
  46. 8.8.3 Daikyo Seiko Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Daikyo Seiko Tubular Injection Vial Product Portfolio
  48. 8.8.5 Daikyo Seiko Recent Developments
  49. 8.9 West Pharmaceutical
  50. 8.9.1 West Pharmaceutical Company Information
  51. 8.9.2 West Pharmaceutical Business Overview
  52. 8.9.3 West Pharmaceutical Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 West Pharmaceutical Tubular Injection Vial Product Portfolio
  54. 8.9.5 West Pharmaceutical Recent Developments
  55. 8.10 Radpharm Scientific
  56. 8.10.1 Radpharm Scientific Company Information
  57. 8.10.2 Radpharm Scientific Business Overview
  58. 8.10.3 Radpharm Scientific Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Radpharm Scientific Tubular Injection Vial Product Portfolio
  60. 8.10.5 Radpharm Scientific Recent Developments
  61. 8.11 Pacific Vial Manufacturing
  62. 8.11.1 Pacific Vial Manufacturing Company Information
  63. 8.11.2 Pacific Vial Manufacturing Business Overview
  64. 8.11.3 Pacific Vial Manufacturing Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Pacific Vial Manufacturing Tubular Injection Vial Product Portfolio
  66. 8.11.5 Pacific Vial Manufacturing Recent Developments
  67. 8.12 Ningbo Zhengli Pharmaceutical Packaging
  68. 8.12.1 Ningbo Zhengli Pharmaceutical Packaging Company Information
  69. 8.12.2 Ningbo Zhengli Pharmaceutical Packaging Business Overview
  70. 8.12.3 Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  72. 8.12.5 Ningbo Zhengli Pharmaceutical Packaging Recent Developments
  73. 8.13 Linuo Pharmaceutical Packaging
  74. 8.13.1 Linuo Pharmaceutical Packaging Company Information
  75. 8.13.2 Linuo Pharmaceutical Packaging Business Overview
  76. 8.13.3 Linuo Pharmaceutical Packaging Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Linuo Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  78. 8.13.5 Linuo Pharmaceutical Packaging Recent Developments
  79. 8.14 Chongqing Zhengchuan Pharmaceutical Packaging
  80. 8.14.1 Chongqing Zhengchuan Pharmaceutical Packaging Company Information
  81. 8.14.2 Chongqing Zhengchuan Pharmaceutical Packaging Business Overview
  82. 8.14.3 Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  84. 8.14.5 Chongqing Zhengchuan Pharmaceutical Packaging Recent Developments
  85. 8.15 Shandong Pharmaceutical Glass
  86. 8.15.1 Shandong Pharmaceutical Glass Company Information
  87. 8.15.2 Shandong Pharmaceutical Glass Business Overview
  88. 8.15.3 Shandong Pharmaceutical Glass Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Shandong Pharmaceutical Glass Tubular Injection Vial Product Portfolio
  90. 8.15.5 Shandong Pharmaceutical Glass Recent Developments
  91. 8.16 CANGZHOU FOUR STARS GLASS
  92. 8.16.1 CANGZHOU FOUR STARS GLASS Company Information
  93. 8.16.2 CANGZHOU FOUR STARS GLASS Business Overview
  94. 8.16.3 CANGZHOU FOUR STARS GLASS Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CANGZHOU FOUR STARS GLASS Tubular Injection Vial Product Portfolio
  96. 8.16.5 CANGZHOU FOUR STARS GLASS Recent Developments
  97. 8.17 Anhui Huaxin Pharmaceutical Glass Products
  98. 8.17.1 Anhui Huaxin Pharmaceutical Glass Products Company Information
  99. 8.17.2 Anhui Huaxin Pharmaceutical Glass Products Business Overview
  100. 8.17.3 Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Product Portfolio
  102. 8.17.5 Anhui Huaxin Pharmaceutical Glass Products Recent Developments
  103. 8.18 Jiyuan Zhengyu Industrial
  104. 8.18.1 Jiyuan Zhengyu Industrial Company Information
  105. 8.18.2 Jiyuan Zhengyu Industrial Business Overview
  106. 8.18.3 Jiyuan Zhengyu Industrial Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Jiyuan Zhengyu Industrial Tubular Injection Vial Product Portfolio
  108. 8.18.5 Jiyuan Zhengyu Industrial Recent Developments
  109. 8.19 Taian Youlyy Industrial
  110. 8.19.1 Taian Youlyy Industrial Company Information
  111. 8.19.2 Taian Youlyy Industrial Business Overview
  112. 8.19.3 Taian Youlyy Industrial Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Taian Youlyy Industrial Tubular Injection Vial Product Portfolio
  114. 8.19.5 Taian Youlyy Industrial Recent Developments
  115. 8.20 Nantong Xinde Medical Packing Material
  116. 8.20.1 Nantong Xinde Medical Packing Material Company Information
  117. 8.20.2 Nantong Xinde Medical Packing Material Business Overview
  118. 8.20.3 Nantong Xinde Medical Packing Material Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Nantong Xinde Medical Packing Material Tubular Injection Vial Product Portfolio
  120. 8.20.5 Nantong Xinde Medical Packing Material Recent Developments
  121. 8.21 Chengdu Jingu Medicinal Packing
  122. 8.21.1 Chengdu Jingu Medicinal Packing Company Information
  123. 8.21.2 Chengdu Jingu Medicinal Packing Business Overview
  124. 8.21.3 Chengdu Jingu Medicinal Packing Tubular Injection Vial Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Chengdu Jingu Medicinal Packing Tubular Injection Vial Product Portfolio
  126. 8.21.5 Chengdu Jingu Medicinal Packing Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tubular Injection Vial Value Chain Analysis
  2. 9.1.1 Tubular Injection Vial Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tubular Injection Vial Sales Mode & Process
  6. 9.2 Tubular Injection Vial Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tubular Injection Vial Distributors
  9. 9.2.3 Tubular Injection Vial Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst